Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/26538148/ below:

Intermediate-risk patients with three to four small adenomas should be considered low risk for colorectal cancer screening

Affiliations

• ¹ Department of Gastroenterology, Morales Meseguer Hospital, Alicante, Spain.
• ² Department of Gastroenterology, Alicante University Hospital, Alicante, Spain.
• ³ Colorectal Cancer Prevention Program for Región de Murcia, Servicio Murciano de Salud, Murcia, Spain.

• PMID: 26538148
• DOI: 10.1111/den.12570

Item in Clipboard

Enrique Pérez-Cuadrado-Robles et al. Dig Endosc. 2016 May.

• ¹ Department of Gastroenterology, Morales Meseguer Hospital, Alicante, Spain.
• ² Department of Gastroenterology, Alicante University Hospital, Alicante, Spain.
• ³ Colorectal Cancer Prevention Program for Región de Murcia, Servicio Murciano de Salud, Murcia, Spain.

• PMID: 26538148
• DOI: 10.1111/den.12570

Item in Clipboard

Background and aim: Intermediate-risk patients following a colorectal cancer screening program may have differential risk of advanced lesions depending on the findings of an index colonoscopy. The aim of the present study was to comparatively assess advanced colorectal neoplasia risk at the first follow-up colonoscopy among the different intermediate-risk subgroups with a focus on patients with three to four adenomas.

Methods: All patients recruited for a baseline screening colonoscopy between 2006 and 2011 were included. Number, size and histopathological characteristics of adenomas were collected. Main outcome was an advanced colorectal neoplasia detection rate (invasive carcinoma or advanced adenoma) at the first follow-up colonoscopy. Low- and high-risk patients were excluded.

Results: Five hundred and sixty-one intermediate-risk patients (63.3% men, mean age: 59.01 ± 6.16 years) underwent indexing and follow-up colonoscopy. By multivariate analysis, three to four adenomas (OR: 3.613 [95% CI: 1.661-7.859], P = 0.001) and adenoma size ≥10 <20 mm (OR: 3.374 [95% CI: 1.618-7.034], P = 0.001) were independent factors associated with advanced colorectal neoplasia. Advanced lesions were detected in 7.66% of cases. Of patients with advanced colorectal neoplasia, 51.16% belonged to the three-to-four-adenoma group and ≥1 of ≥10 <20-mm subgroups (n = 132, 23.53%). These patients demonstrated a higher rate of advanced lesions [OR: 3.886 (95% CI: 2.061-7.325), P < 0.001] than patients with three to four small adenomas of <10 mm (16.67% vs 5.07%, P < 0.001). The association between patients with small adenomas (n = 217, 38.68%) and advanced lesions was not significant (OR: 0.521 [95% CI: 0257-1.056], P = 0.066).

Conclusion: Intermediate-risk patients with three to four small adenomas achieved a very low advanced lesion rate at follow up. Surveillance interval should be lengthened because these patients should be considered low risk.

Keywords: adenoma; advanced adenoma (AA); colorectal cancer screening; colorectal neoplasm; risk.

© 2015 Japan Gastroenterological Endoscopy Society.

PubMed Disclaimer

• Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome.

  Anderson JC, Baron JA, Ahnen DJ, Barry EL, Bostick RM, Burke CA, Bresalier RS, Church TR, Cole BF, Cruz-Correa M, Kim AS, Mott LA, Sandler RS, Robertson DJ. Anderson JC, et al. Gastroenterology. 2017 Jun;152(8):1933-1943.e5. doi: 10.1053/j.gastro.2017.02.010. Epub 2017 Feb 20. Gastroenterology. 2017. PMID: 28219690 Free PMC article. Clinical Trial.

• [Development of colorectal advanced neoplasia/adenomas in the long-term follow-up of patients submitted to colonoscopy with polipectomy].

  Rostirolla RA, Pereira-Lima JC, Teixeira CR, Schuch AW, Perazzoli C, Saul C. Rostirolla RA, et al. Arq Gastroenterol. 2009 Jul-Sep;46(3):167-72. doi: 10.1590/s0004-28032009000300005. Arq Gastroenterol. 2009. PMID: 19918680 Portuguese.

• Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer: a retrospective cohort study.

  Cross AJ, Robbins EC, Pack K, Stenson I, Kirby PL, Patel B, Rutter MD, Veitch AM, Saunders BP, Little M, Gray A, Duffy SW, Wooldrage K. Cross AJ, et al. Health Technol Assess. 2022 May;26(26):1-156. doi: 10.3310/OLUE3796. Health Technol Assess. 2022. PMID: 35635015 Free PMC article.

• Systematic review with meta-analysis: the incidence of advanced neoplasia after polypectomy in patients with and without low-risk adenomas.

  Hassan C, Gimeno-García A, Kalager M, Spada C, Zullo A, Costamagna G, Senore C, Rex DK, Quintero E. Hassan C, et al. Aliment Pharmacol Ther. 2014 May;39(9):905-12. doi: 10.1111/apt.12682. Epub 2014 Mar 4. Aliment Pharmacol Ther. 2014. PMID: 24593121 Review.

• High-risk family colorectal cancer screening service in Ireland: Critical review of clinical outcomes.

  Walshe M, Moran R, Boyle M, Cretu I, Galvin Z, Swan V, Trikovic J, Farrell MP, Foy S, O'Brien L, Leyden J, Mulligan N, Fenlon H, Gallagher DJ, MacMathúna P. Walshe M, et al. Cancer Epidemiol. 2017 Oct;50(Pt A):30-38. doi: 10.1016/j.canep.2017.07.002. Epub 2017 Aug 4. Cancer Epidemiol. 2017. PMID: 28783501 Review.

• Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer.

  Gupta S, Lieberman D, Anderson JC, Burke CA, Dominitz JA, Kaltenbach T, Robertson DJ, Shaukat A, Syngal S, Rex DK. Gupta S, et al. Gastroenterology. 2020 Mar;158(4):1131-1153.e5. doi: 10.1053/j.gastro.2019.10.026. Epub 2020 Feb 7. Gastroenterology. 2020. PMID: 32044092 Free PMC article. No abstract available.

• Impact of the European Society of Gastrointestinal Endoscopy 2020 guidelines on the number of scheduled post-polypectomy surveillance colonoscopies: Meeting presentations: Partial results of this research were published in abstract form at ESGE Days 2020.

  Bustamante-Balén M, García-Campos M, Lorenzo-Zúñiga V, Alonso-Lázaro N, Sanchez-Montes C, Argüello-Viudez L, Pons-Beltrán V. Bustamante-Balén M, et al. Endosc Int Open. 2022 Sep 14;10(9):E1238-E1244. doi: 10.1055/a-1905-0155. eCollection 2022 Sep. Endosc Int Open. 2022. PMID: 36118644 Free PMC article.

• Provider Adherence to the 2020 US Multi-Society Task Force Guidelines for Surveillance After Colonoscopy With Polypectomy.

  Cassell BE, Scholand K, Tarter W, Hochheimer CJ, Long C, Austin GL. Cassell BE, et al. Gastro Hep Adv. 2024 Aug 23;4(1):100532. doi: 10.1016/j.gastha.2024.08.011. eCollection 2025. Gastro Hep Adv. 2024. PMID: 39790238 Free PMC article.

• Low Incidence of Colorectal Advanced Neoplasia During Surveillance in Individuals with a Family History of Colorectal Cancer.

  Barnett MI, Wassie MM, Cock C, Bampton PA, Symonds EL. Barnett MI, et al. Dig Dis Sci. 2023 Nov;68(11):4243-4251. doi: 10.1007/s10620-023-08053-6. Epub 2023 Sep 8. Dig Dis Sci. 2023. PMID: 37682374 Free PMC article.

• Total polyp number may be more important than size and histology of polyps for prediction of metachronous high-risk colorectal neoplasms.

  Yoon H, Shin CM, Park YS, Kim N, Lee DH. Yoon H, et al. BMC Gastroenterol. 2022 Mar 2;22(1):91. doi: 10.1186/s12876-022-02177-1. BMC Gastroenterol. 2022. PMID: 35236287 Free PMC article.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3